Pfizer PFE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 73.5%+1.2pp | 74.3%+2.4pp | 73.4%+5.7pp | 72.1%+13.9pp | 72.3%+14.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×0.0× | 1.2×0.0× | 1.3×+0.3× | 1.2×+0.3× | 1.3×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.7×0.0× | 0.8×+0.1× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Per Share | ||||||
| Book value per share | $15.72-0.6% | $15.14-2.2% | $16.24+0.4% | $15.54+1.0% | $15.82-2.3% | |
| Valuation | ||||||
| Market capitalization | $159.73B+11.1% | $141.57B-5.8% | $144.87B-11.7% | $138.21B-12.7% | $143.71B-8.5% | |
| Price / sales | 2.5×+0.2× | 2.3×-0.1× | 2.3×-0.4× | 2.2×-0.7× | 2.3×-0.5× | |
| Price / book | 1.8×+0.2× | 1.6×-0.1× | 1.6×-0.2× | 1.6×-0.2× | 1.6×-0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Pfizer's ratios come from?
- Every ratio is computed from Pfizer's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
